Correlation Between PDS Biotechnology and Axsome Therapeutics
Can any of the company-specific risk be diversified away by investing in both PDS Biotechnology and Axsome Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PDS Biotechnology and Axsome Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PDS Biotechnology Corp and Axsome Therapeutics, you can compare the effects of market volatilities on PDS Biotechnology and Axsome Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PDS Biotechnology with a short position of Axsome Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of PDS Biotechnology and Axsome Therapeutics.
Diversification Opportunities for PDS Biotechnology and Axsome Therapeutics
-0.57 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between PDS and Axsome is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding PDS Biotechnology Corp and Axsome Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Axsome Therapeutics and PDS Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PDS Biotechnology Corp are associated (or correlated) with Axsome Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Axsome Therapeutics has no effect on the direction of PDS Biotechnology i.e., PDS Biotechnology and Axsome Therapeutics go up and down completely randomly.
Pair Corralation between PDS Biotechnology and Axsome Therapeutics
Given the investment horizon of 90 days PDS Biotechnology Corp is expected to under-perform the Axsome Therapeutics. In addition to that, PDS Biotechnology is 2.09 times more volatile than Axsome Therapeutics. It trades about -0.35 of its total potential returns per unit of risk. Axsome Therapeutics is currently generating about 0.17 per unit of volatility. If you would invest 9,011 in Axsome Therapeutics on August 27, 2024 and sell it today you would earn a total of 857.00 from holding Axsome Therapeutics or generate 9.51% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
PDS Biotechnology Corp vs. Axsome Therapeutics
Performance |
| Timeline |
| PDS Biotechnology Corp |
| Axsome Therapeutics |
PDS Biotechnology and Axsome Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with PDS Biotechnology and Axsome Therapeutics
The main advantage of trading using opposite PDS Biotechnology and Axsome Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PDS Biotechnology position performs unexpectedly, Axsome Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Axsome Therapeutics will offset losses from the drop in Axsome Therapeutics' long position.| PDS Biotechnology vs. Mereo BioPharma Group | PDS Biotechnology vs. Terns Pharmaceuticals | PDS Biotechnology vs. Inozyme Pharma | PDS Biotechnology vs. Hookipa Pharma |
| Axsome Therapeutics vs. Incyte | Axsome Therapeutics vs. Sarepta Therapeutics | Axsome Therapeutics vs. ACADIA Pharmaceuticals | Axsome Therapeutics vs. Viking Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |